Skip to main content
Global
Global Fin Swe Nor Den Ger Cze Svk Pol Nld Bel (nl) Bel (fr) USA
Log in
  • Aidian – Your aid in diagnostics
  • Point-of-care testing
  • Products
  • About us
  • News
  • Antimicrobial resistance
  • Customer stories
  • Events
  • For distributors / Log in
Contact us Search
Logo
Contact us
  • Point of care
  • Microbiology
  • Molecular diagnostics
  • Hygiene monitoring
  • RIA / Collagens
  • Respiratory tract infections
  • Products available in the USA
Point of care
  • QuikRead go system
  • QuikRead 101
Read more
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go accessories
QuikRead go
Microbiology
  • Uricult
  • Uricult Vet
  • Cultura M
Read more
Molecular diagnostics
  • SIBA
Read more
SIBA licensing and partnering opportunities
Read more
Hygiene monitoring
  • Easicult
  • Hygicult
  • Clean Card PRO
Read more
NEW! A comprehensive guide to monitoring surface hygiene now published
Read more
RIA / Collagens
  • UniQ
Read more
  • Our history
  • Board and management
  • Sustainability
  • Culture
  • Careers
  • Employee stories
  • Partnering and licensing
  • UN Global Compact Commitment | Aidian
  • News
  • Product news
  • AMR
  • Events
  • Stories from customers
  • COVID-19
  • About C-reactive protein (CRP)
  • AMR interview
  • CRP and lower respiratory tract infections
  • Educational materials
  • QuikRead go CRP products
  • Spreading of antibiotic resistant bacteria
  • Useful links
  • Sleeping hygiene: monitoring cleanliness of pillows and bedding
Modify Selected Code…
Contact us Close
  • Point-of-care testing
  • Products
    • Point of care
      • QuikRead go system
      • QuikRead 101
    • Microbiology
      • Uricult
      • Uricult Vet
      • Cultura M
    • Molecular diagnostics
      • SIBA
    • Hygiene monitoring
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Collagens
      • UniQ
    • Respiratory tract infections
    • Products available in the USA
  • About us
    • Our history
    • Board and management
    • Sustainability
    • Culture
    • Careers
    • Employee stories
    • Partnering and licensing
    • UN Global Compact Commitment | Aidian
  • News
    • News
    • Product news
    • AMR
    • Events
    • Stories from customers
    • COVID-19
  • Antimicrobial resistance
    • About C-reactive protein (CRP)
    • AMR interview
    • CRP and lower respiratory tract infections
    • Educational materials
    • QuikRead go CRP products
    • Spreading of antibiotic resistant bacteria
    • Useful links
  • Customer stories
    • Sleeping hygiene: monitoring cleanliness of pillows and bedding
  • Events
  • For distributors / Log in
Popular products
QuikRead go Plus Instrument

QuikRead go Plus Instrument

QuikRead go HbA1c

QuikRead go HbA1c

SIBA

SIBA

Latest news
View all

World Diabetes Day: driving awareness and action

November 14, 2025 | News

Aidian receives the Mental Health Friendly Workplace label!

September 15, 2025 | News

Aidian welcomes Tarja Hirvensalo as its new CTO

August 22, 2025 | News

  • View all
  • No results found
  • Loading...
News

World Diabetes Day: driving awareness and action

November 14, 2025 | News

Aidian receives the Mental Health Friendly Workplace label!

September 15, 2025 | News

Back to all news
November 14, 2025
News

World Diabetes Day: driving awareness and action

Diabetes is one of the fastest-growing health challenges of our time

November 14th marks World Diabetes Day – a global initiative aimed at raising awareness about diabetes. Diabetes is among the fastest-growing health emergencies of the 21st century, affecting millions worldwide.1

In 2024, an estimated 589 million adults aged 20–79 were living with diabetes worldwide, representing 11.1% of the world’s population in this age group (1 in 9). By 2050 this number is projected to rise to 853 million.1 This increase can lead to higher rates of diabetes-related complications, increased pressure on healthcare systems, and substantial economic burdens due to rising healthcare costs and productivity losses.  

Alarmingly, 43% of people with diabetes remain undiagnosed, predominantly type 2 diabetes. This highlights the urgent need to strengthen early detection efforts. 1

Early detection and effective management are key to reducing complications

Detecting diabetes early and initiating treatment promptly are essential steps in managing the disease and preventing complications. 1

At Aidian, we are dedicated to improving diabetes management through our point-of-care testing (POCT) solutions. We want to highlight the impact of diabetes and the importance of early detection and effective management.

Glycated haemoglobin (HbA1c) test helps to monitor long-term blood glucose control in diabetic patients, and it also supports the identification of people at risk of developing diabetes. Point-of-care HbA1c testing has been shown to enhance diabetes management, increase patient’s commitment to treatment and improve patient satisfaction. These are leading to improved glycaemic control and reduced risk of costly and harmful comorbidities.2-4

Regular check-ups of average blood sugar levels are crucial to detect prediabetes or diabetes early. Learn more about our QuikRead go HbA1c test.

Let’s spread awareness and support those affected by diabetes. 
 

References:

  1. International Diabetes Federation. IDF Diabetes atlas, 11th edition 2025.
  2. Miller CD et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 2003; 26(4): 1158-1163.
  3. Schnell O et al. Impact of HbA1c Testing at Point of Care on Diabetes Management. J Diabetes Sci Technol 2017; 11(3):611-617.
  4. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024. Diabetes Care 2024; 47:S20-S42.
     
Share
Facebook
Twitter
Email

Aidian Oy

Koivu-Mankkaan tie 6 B
FI-02200 Espoo Finland
P.O. Box 83
FI-02101 Espoo Finland

 

+358 10 309 3000

Company
  • About us
  • Careers
  • Contact us
  • Events
  • Product-specific inquiries
  • Sales support
  • Sales related inquiries
  • Sustainability
Products
  • Point of care
  • Microbiology
  • Molecular diagnostics
  • Hygiene monitoring
  • RIA / Collagens
  • Respiratory tract infections
Quick links
  • Aidian Academy
  • Aidian Connect
  • IFU Revision histories
Copyright © 2025 Aidian
  • Privacy
  • Privacy Statements
  • Cookie Policy
  • Social Media Policy